JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 53(2019) N 6 p. 862-875; DOI 10.1134/S0026893319060116 Full Text

N.A. Lomov1,2*, V.S. Viushkov1,2, A.P. Petrenko1, M.S. Syrkina1,2, M.A. Rubtsov1,2,3**

Methods of Evaluating the Efficiency of CRISPR/Cas Genome Editing

1Moscow State University, Moscow, 119991 Russia
2LIA LFR20 Laboratoire Franco-Russe de Recherches en Oncologie, Moscow State University, Moscow, 119991 Russia
3Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119991 Russia

*lomov13@gmail.com
**ma_rubtsov@mail.ru
Received - 2019-05-16; Revised - 2019-06-03; Accepted - 2019-07-04

The CRISPR/Cas system is currently widely used for genome editing. The procedure of genome editing includes two necessary steps: (i) searching for the most effective guide RNA, and (ii) analyzing clones for presence of the desired mutation. This review presents the methods used to assess the efficiency of the CRISPR/Cas system and to confirm mutation in the target locus and discusses their advantages and disadvantages. It aims to provide information that could help researchers to choose a technique most appropriate for their specific tasks and available resources.

CRISPR/Сas9, NGS, droplet digital PCR, RFLP, T7E1, SURVEYOR, TIDE, IDAA, pDR/FACS, ENIT, SNP, HRMA, SSCP, cbPCR, DHPLC, LDR



JMB-FOOTER RAS-JOURNALS